TENAX THERAPEUTICS, INC. Conversion of Stock, Shares Issued
TENAX THERAPEUTICS, INC. (TENX) reported Conversion of Stock, Shares Issued of 1.21 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2023-03-31
- TENAX THERAPEUTICS, INC. conversion of stock, shares issued for the quarter ending 2022-12-31 was 0.00 shares.
- TENAX THERAPEUTICS, INC. conversion of stock, shares issued for the quarter ending 2022-09-30 was 0.00 shares.
- TENAX THERAPEUTICS, INC. conversion of stock, shares issued for the quarter ending 2022-06-30 was 0.00 shares.
- TENAX THERAPEUTICS, INC. conversion of stock, shares issued for the quarter ending 2022-03-31 was 1.21M shares.
- TENAX THERAPEUTICS, INC. conversion of stock, shares issued for fiscal 2022 was 1.21M shares, a 0.00% change from fiscal 2021.
- TENAX THERAPEUTICS, INC. conversion of stock, shares issued for fiscal 2021 was 1.21M shares.
| Period end | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 6 month | Conversion of Stock, Shares Issued 9 month | Conversion of Stock, Shares Issued 12 month |
|---|---|---|---|---|
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-31 | 0.00 shares derived: sum of 3 quarters · filed 2023-03-31 | 1.21M shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-10 | 1.21M shares 10-Q · filed 2022-11-10 | 1.21M shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 1.21M shares 10-Q · filed 2022-08-11 | 1.21M shares derived: sum of 3 quarters · filed 2022-08-11 | 1.21M shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 1.21M shares 10-Q · filed 2022-05-16 | 1.21M shares derived: sum of 2 quarters · filed 2022-05-16 | 1.21M shares derived: sum of 3 quarters · filed 2022-05-16 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-29 | 1.21M shares 10-K · filed 2022-03-29 | |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 1.21M shares 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | 1.21M shares 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |